Literature DB >> 19484669

Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.

Daniella Cunha Brandao1, Vitoria Maria Lima, Valdecir Galindo Filho, Thayse Santos Silva, Tania Fernandes Campos, Elizabeth Dean, Armele Dornelas de Andrade.   

Abstract

Jet nebulization (JN) and non-invasive mechanical ventilation (NIMV) through bi-level pressure is commonly used in emergency and intensive care of patients experiencing an acute exacerbation of asthma. However, a scientific basis for effect of JN coupled with NIMV is unclear. Objective. To evaluate the effect of jet nebulization administered during spontaneous breathing with that of nebulization with NIV at two levels of inspiratory and expiratory pressures resistance in patients experiencing an acute asthmatic episode. Methods. A prospective, randomized controlled study of 36 patients with severe asthma (forced expiratory volume in 1 second [FEV(1)] less than 60% of predicted) selected with a sample of patients who presented to the emergency department. Subjects were randomized into three groups: control group (nebulization with the use of an unpressured mask), experimental group 1 (nebulization and non-invasive positive pressure with inspiratory positive airway pressure [IPAP] = 15 cm H(2)O, and expiratory positive airway pressure [EPAP] = 5 cm H(2)O), and experimental group 2 (nebulization and non-invasive positive pressure with IPAP = 15 cm H(2)O and EPAP = 10 cm H(2)O). Bronchodilators were administered with JN for all groups. Dependent measures were recorded before and after 30 minutes of each intervention and included respiratory rate (RR), heart rate (HR), oxygen saturation (SpO(2)), peak expiratory flow (PEF), forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), and forced expiratory flow between 25 and 75% (FEF(25-75)). Results. The group E2 showed an increase of the peak expiratory flow (PEF), forced vital capacity (FVC), FEV(1) (p < 0.03) and F(25-75%) (p < 0.000) when compared before and 30 minutes after JN+NIMV. In group E1 the PFE (p < 0.000) reached a significant increase after JN+ NIMV. RR decreased before and after treatment in group E1 only (p = 0.04). Conclusion. Nebulization coupled with NIV in patients with acute asthma has the potential to reduce bronchial obstruction and symptoms secondary to augmented PEF compared with nebulization during spontaneous breathing. In reversing bronchial obstruction, this combination appears to be more efficacious when a low pressure delta is used in combination with a high positive pressure at the end of expiration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484669     DOI: 10.1080/02770900902718829

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  11 in total

1.  Management of severe asthma exacerbation in children.

Authors:  Xiao-Fang Wang; Jian-Guo Hong
Journal:  World J Pediatr       Date:  2011-10-20       Impact factor: 2.764

2.  Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth.

Authors:  Ross L Walenga; P Worth Longest; Anubhav Kaviratna; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-01-11       Impact factor: 2.849

3.  Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations.

Authors:  Meghan D Althoff; Fernando Holguin; Fan Yang; Gary K Grunwald; Marc Moss; R William Vandivier; P Michael Ho; Tyree H Kiser; Ellen L Burnham
Journal:  Am J Respir Crit Care Med       Date:  2020-12-01       Impact factor: 21.405

4.  Failure of noninvasive ventilation in adult patients with acute asthma exacerbation.

Authors:  Mabrouk Bahloul; Kamilia Chtara; Rahma Gargouri; Ali Majdoub; Anis Chaari; Mounir Bouaziz
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

5.  Paediatric ED BiPAP continuous quality improvement programme with patient analysis: 2005-2013.

Authors:  Thomas Abramo; Abby Williams; Samaiya Mushtaq; Mark Meredith; Rawle Sepaule; Kristen Crossman; Cheryl Burney Jones; Suzanne Godbold; Zhuopei Hu; Todd Nick
Journal:  BMJ Open       Date:  2017-01-16       Impact factor: 2.692

Review 6.  Non-invasive positive pressure ventilation for acute asthma in children.

Authors:  Steven Kwasi Korang; Joshua Feinberg; Jørn Wetterslev; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2016-09-30

7.  Nasal High-flow Oxygen Versus Conventional Oxygen Therapy for Acute Severe Asthma Patients: A Pilot Randomized Controlled Trial.

Authors:  Onlak Ruangsomboon; Chok Limsuwat; Nattakarn Praphruetkit; Apichaya Monsomboon; Tipa Chakorn
Journal:  Acad Emerg Med       Date:  2020-12-22       Impact factor: 3.451

Review 8.  Fundamentals of aerosol therapy in critical care.

Authors:  Jayesh Dhanani; John F Fraser; Hak-Kim Chan; Jordi Rello; Jeremy Cohen; Jason A Roberts
Journal:  Crit Care       Date:  2016-10-07       Impact factor: 9.097

Review 9.  Inhalation Techniques Used in Patients with Respiratory Failure Treated with Noninvasive Mechanical Ventilation.

Authors:  Patrycja Rzepka-Wrona; Szymon Skoczynski; Dawid Wrona; Adam Barczyk
Journal:  Can Respir J       Date:  2018-06-03       Impact factor: 2.409

Review 10.  Management of severe asthma exacerbation: guidelines from the Société Française de Médecine d'Urgence, the Société de Réanimation de Langue Française and the French Group for Pediatric Intensive Care and Emergencies.

Authors:  Philippe Le Conte; Nicolas Terzi; Guillaume Mortamet; Fekri Abroug; Guillaume Carteaux; Céline Charasse; Anthony Chauvin; Xavier Combes; Stéphane Dauger; Alexandre Demoule; Thibaut Desmettre; Stephan Ehrmann; Bénédicte Gaillard-Le Roux; Valérie Hamel; Boris Jung; Sabrina Kepka; Erwan L'Her; Mikaël Martinez; Christophe Milési; Élise Morawiec; Mathieu Oberlin; Patrick Plaisance; Robin Pouyau; Chantal Raherison; Patrick Ray; Mathieu Schmidt; Arnaud W Thille; Jennifer Truchot; Guillaume Valdenaire; Julien Vaux; Damien Viglino; Guillaume Voiriot; Bénédicte Vrignaud; Sandrine Jean; Eric Mariotte; Pierre-Géraud Claret
Journal:  Ann Intensive Care       Date:  2019-10-10       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.